Publications by authors named "Youra Kim"

Claim this Profile
A
After virus exposure, early bystander naïve CD8 T cell activation relies on NAD salvage metabolism.
Namit Holay, Barry E Kennedy, J Patrick Murphy, Prathyusha Konda, Michael Giacomantonio, Youra Kim

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities.
Youra Kim, Prathyusha Konda, J Patrick Murphy, Joao A Paulo, Steven P Gygi

Mol Cell Proteomics· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma.
Juliette Paillet, Céleste Plantureux, Sarah Lévesque, Julie Le Naour, Gautier Stoll, Youra Kim

J Exp Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing CD8 T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?
Shashi Gujar, Jonathan G Pol, Youra Kim, Guido Kroemer

Oncoimmunology· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Proteome Responses to Oncolytic Reovirus in GM-CSF- and M-CSF-Differentiated Bone Marrow-Derived Cells.
Michael A Giacomantonio, Andra M Sterea, Youra Kim, Joao A Paulo, Derek R Clements

J Proteome Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Pyruvate Dehydrogenase Kinase Enhances the Antitumor Efficacy of Oncolytic Reovirus.
Barry E Kennedy, John Patrick Murphy, Derek R Clements, Prathyusha Konda, Namit Holay, Youra Kim

Cancer Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy.
J Patrick Murphy, Youra Kim, Derek R Clements, Prathyusha Konda, Heiko Schuster

J Proteome Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplexed Relative Quantitation with Isobaric Tagging Mass Spectrometry Reveals Class I Major Histocompatibility Complex Ligand Dynamics in Response to Doxorubicin.
J Patrick Murphy, Qijia Yu, Prathyusha Konda, Joao A Paulo, Mark P Jedrychowski, Youra Kim

Anal Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NAD Salvage Pathway Supports PHGDH-Driven Serine Biosynthesis.
J Patrick Murphy, Michael A Giacomantonio, Joao A Paulo, Robert A Everley, Barry E Kennedy, Youra Kim

Cell Rep· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Silencing of TAP1 in Aldefluor Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion.
Mohammad Sultan, Dejan Vidovic, Arianne S Paine, Thomas T Huynh, Krysta M Coyle, Youra Kim

Stem Cells· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies.
Shashi Gujar, Jonathan G Pol, Youra Kim, Patrick W Lee, Guido Kroemer

Trends Immunol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis.
Jordan R Warford, Anna-Claire Lamport, Derek R Clements, Alicia Malone, Barry E Kennedy, Youra Kim

Acta Neuropathol Commun· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Temporal in Vivo Proteomics Deciphers the Transition of Virus-Driven Myeloid Cells into M2 Macrophages.
Derek R Clements, John Patrick Murphy, Andra Sterea, Barry E Kennedy, Youra Kim

J Proteome Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines.
Namit Holay, Youra Kim, Patrick Lee, Shashi Gujar

Front Immunol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies.
J Patrick Murphy, Prathyusha Konda, Daniel J Kowalewski, Heiko Schuster, Derek Clements, Youra Kim

J Proteome Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagic homeostasis is required for the pluripotency of cancer stem cells.
Tanveer Sharif, Emma Martell, Cathleen Dai, Barry E Kennedy, Patrick Murphy, Youra Kim

Autophagy· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAD salvage pathway in cancer metabolism and therapy.
Barry E Kennedy, Tanveer Sharif, Emma Martell, Cathleen Dai, Youra Kim

Pharmacol Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy.
Youra Kim, Derek R Clements, Andra M Sterea, Hyun Woo Jang, Shashi A Gujar

Viruses· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy.
Derek R Clements, Youra Kim, Shashi A Gujar, Patrick Wk Lee

Oncoimmunology· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newly recruited CD11b+, GR-1+, Ly6C(high) myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus.
Derek R Clements, Andra M Sterea, Youra Kim, Erin Helson, Cheryl A Dean

J Immunol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Francisella tularensis uses cholesterol and clathrin-based endocytic mechanisms to invade hepatocytes.
H T Law, Ann En-Ju Lin, Youra Kim, Brian Quach, Francis E Nano

Sci Rep· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis